Outlook Therapeutics

About:

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

Website: https://outlooktherapeutics.com

Twitter/X: OutlookTx

Top Investors: Perceptive Advisors, Great Point Partners, venBio Partners, Schonfeld Strategic Advisors, Woodline Partners

Description:

Outlook Therapeutics develops an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration, diabetic macular edema, and branch retinal vein occlusion. Their ophthalmic formulations also use in treating retinal diseases.